42 results on '"Pilewski, Joseph M."'
Search Results
2. Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
3. Systems serology in cystic fibrosis: Anti-Pseudomonas IgG1 responses and reduced lung function
4. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
5. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications
6. Position paper: Models of post-transplant care for individuals with cystic fibrosis
7. Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
8. Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
9. Outpatient Pharmacologic Management of Lung Transplant Candidates on the Waiting List
10. Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients
11. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
12. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction
13. Challenges in the use of highly effective modulator treatment for cystic fibrosis
14. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction
15. Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy
16. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease
17. Prevalence of unmet palliative care needs in adults with cystic fibrosis
18. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study
19. Routine deep vein thrombosis screening after lung transplantation: Incidence and risk factors
20. Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines
21. Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis
22. Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis
23. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study
24. Provider Attitudes and Practices toward Sexual and Reproductive Health Care for Young Women with Cystic Fibrosis
25. A longitudinal analysis of respiratory symptoms in people with cystic fibrosis with advanced lung disease on and off ETI
26. Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States
27. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation
28. Delayed chest closure after lung transplantation: Techniques, outcomes, and strategies
29. Nature and correlates of post-traumatic stress symptomatology in lung transplant recipients
30. Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
31. Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study
32. Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant: Midterm Outcomes
33. Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation: Long-Term Survival
34. Evaluation of humoral immunity in end-stage lung disease
35. Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival
36. Sequential redo-bilateral lung transplantation in recipient with prior heart-lung transplantation with tracheal anastomosis
37. Successful lung transplantation from a hepatitis C RNA–positive donor to a hepatitis C treatment–experienced recipient with cystic fibrosis
38. Humoral Immunity in End-Stage Lung Disease Prior to Lung Transplantation
39. Low IgG2 Level and Increased Risk of Infections in Lung Transplant Recipients
40. Sexual and Reproductive Health Care Utilization and Preferences of Young Women With Cystic Fibrosis
41. Lessons Learned From Strategy to Become a High-Volume Lung Transplant Center
42. PROSPECTIVE ASSESSMENT OF DIAGNOSTIC UTILITY OF DIFFERENT BRONCHOSCOPY SAMPLING MODALITIES FOR BACTERIAL PNEUMONIA IN LUNG TRANSPLANT RECIPIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.